Heterogeneity Among Liver Cancer--A Hurdle to Optimizing Therapy.

Gastroenterology ·Vol. 150 ·No. 4 ·2016-04-00 ·Pages 818-21

Birkbak NJ, Andersen JB

Abstract

暂无摘要

MeSH Terms

Biomarkers, Tumor/genetics Carcinoma, Hepatocellular/genetics Humans Liver Neoplasms/genetics Mutation Neoplasms, Multiple Primary/genetics

Chemicals

Biomarkers, Tumor

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Birkbak Nicolai Juul

The Francis Crick Institute, London, United Kingdom; University College London Cancer Institute, London, United Kingdom.

Andersen Jesper B

Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark. Electronic address: Jesper.andersen@bric.ku.dk.

Article Info

Journal

Gastroenterology

Abbr.

Gastroenterology

ISSN

1528-0012

DOI

Published

2016-04-00

Epub

2016-00-26

Pages

818-21

Language

English

Region

United States

NLM ID

0374630

Subset

Corrections

CommentOn

PMID: 26752112

External Links

Analysis Services